Clinical & Translational Research Center (CTRC)

Chapel Hill, North Carolina 27599-7080

1 studies enrolling now · 6 studies all time

What they study most

Active Nonsegmental Vitiligo, Alopecia Areata, Crohn's Disease, Sickle Cell Disease, Stable Nonsegmental Vitiligo, Ulcerative Colitis, Vitiligo

Studies at this site

• A Phase 2/3 Study in Adult and Adolescent Participants With SCD — Recruiting now
• A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata — Running, not enrolling
• A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo — Running, not enrolling
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling